Fuad Novruzov

Baku, BA, Azerbaijan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Correction to: Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Correction to: Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Journal: Nuclear medicine and molecular imaging
Published: December 04, 2025

68Ga-PSMA-11 PET/CT for Initial Staging of Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Predicts Overall Survival: An IAEA Multicenter Study.

68Ga-PSMA-11 PET/CT for Initial Staging of Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Predicts Overall Survival: An IAEA Multicenter Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 05, 2025

68Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, IAEA Study.

68Ga-PSMA-11 in Staging of Unfavorable Intermediate- and High-Risk Prostate Cancer Reduces Indication for Noncurative Prostatectomy: A Prospective, Multicenter, IAEA Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 20, 2025

Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Current Status of Theranostics in West Asia: A Country-based Surveillance Study.

Journal: Nuclear medicine and molecular imaging
Published: January 30, 2025

The true negative [⁶⁸Ga]Ga-Trivehexin PET/CT in Solid Pseudopapillary Neoplasm of pancreas, mimicking pancreatic adenocarcinoma in [¹⁸F]FDG and [⁶⁸Ga]Ga-FAPI scans.

The true negative [⁶⁸Ga]Ga-Trivehexin PET/CT in Solid Pseudopapillary Neoplasm of pancreas, mimicking pancreatic adenocarcinoma in [¹⁸F]FDG and [⁶⁸Ga]Ga-FAPI scans.

Journal: European journal of nuclear medicine and molecular imaging
Published: August 10, 2024

ImmunoPET in high-grade neuroendocrine tumours.

ImmunoPET in high-grade neuroendocrine tumours.

Journal: The Lancet. Oncology
Published: May 21, 2024

Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry.

Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry.

Journal: EJNMMI reports
Published: May 14, 2024

FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review.

FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review.

Journal: Cancers
Published: April 01, 2024

The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma.

The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma.

Journal: PET clinics
Published: April 07, 2023

Controversies of [68Ga]Ga-FAPI-46 and 2-[18F]FDG findings in metastatic melanoma.

Controversies of [68Ga]Ga-FAPI-46 and 2-[18F]FDG findings in metastatic melanoma.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 12, 2022

Diagnostic accuracy of fine needle aspiration biopsy versus postoperative histopathology for diagnosing thyroid malignancy.

Diagnostic accuracy of fine needle aspiration biopsy versus postoperative histopathology for diagnosing thyroid malignancy.

Journal: Endocrinology, diabetes & metabolism
Published: July 19, 2022

Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer.

Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer.

Journal: Molecular imaging and biology
Published: November 10, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026